• PIN19 CLINICAL EFFECTIVENESS AND COST-EFFECTIVENESS OF A POLYMYXIN B-IMMOBILIZED HEMOPERFUSION CARTAGE FOR THE TREATMENT OF SEVERE SEPSIS- A SYSTEMIC REVIEW AND ECONOMIC EVALUATION

    May 1, 2009, 00:00

  • VA1 A MARKOV MODEL EXAMINING THE PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF MASS VACCINATION USING LIVE ATTENUATED HUMAN ROTAVIRUS VACCINE IN A DEVELOPING ASIAN COUNTRY

    May 1, 2009, 00:00

  • PCV27 THE PREDICTION OF STROKE AND MORTALITY OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION MAINTAINING SINUS RHYTHM WITH AND WITHOUT ANTIARRHYTHMIC DRUGS

    May 1, 2009, 00:00

  • PMC28 LINKAGE OF A MULTI-HOSPITAL DATABASE TO HEALTH PLAN CLAIMS DATA FOR CONTINUUM OF CARE OUTCOMES RESEARCH

    May 1, 2009, 00:00

  • PIN44 IDENTIFYING PREDICTORS OF HIV PATIENTS SATISFACTION WITH MAIL-ORDER AND COMMUNITY PHARMACY SERVICES

    May 1, 2009, 00:00

  • PIN16 COST-EFFECTIVENESS ANALYSIS OF POSACONAZOLE FOR PROPHYLAXIS IN PATIENTS WITH NEUTROPENIA IN SOUTH KOREA

    May 1, 2009, 00:00

  • PRS11 QUANTIFYING COSTS AND BENEFITS OF TIMING PHARMACEUTICAL INTERVENTION- AN ECONOMIC SIMULATION MODEL OF ASTHMA IN ALBERTA, CANADA

    May 1, 2009, 00:00

  • PIN47 IMPROVING PHYSICIAN ADHERENCE TO GUIDELINES FOR DRUG THERAPY- A RANDOMIZED CONTROLLED TRIAL OF EDUCATIONAL INTERVENTIONS IN A MANAGED CARE SETTING IN ISRAEL

    May 1, 2009, 00:00

  • PSY38 VALIDATION OF THE TREATMENT RELATED IMPACT MEASURE FOR PRESCRIPTION WEIGHT LOSS MEDICATION IN OBESITY; TRIM-WEIGHT

    May 1, 2009, 00:00

  • PCN50 COST-EFFECTIVENESS OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN PLUS CYCLOPHOSPHAMIDE IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER

    May 1, 2009, 00:00

  • PHP73 HEALTH TECHNOLOGY ASSESSMENT IN DEVELOPING COUNTRIES- WHAT IS THE STATE OF PLAY?

    May 1, 2009, 00:00

  • PSY15 THE IMPACT OF ADHERENCE ON THE COSTS AND BENEFITS OF INTENSIVE LIFESTYLE MANAGEMENT (ILM) IN OVERWEIGHT AND OBESE PATIENTS AT HIGH RISK FOR TYPE-2 DIABETES MELLITUS (T2DM)

    May 1, 2009, 00:00

  • PCN29 THE COST SAVINGS ASSOCIATED WITH BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE (BEVACIZUMAB-BASED THERAPY) TREATMENT COMPARED WITH CETUXIMAB PLUS VINORELBINE AND CISPLATIN (CETUXIMAB-BASED THERAPY) IN PATIENTS WITH ADVANCED OR RECURRENT ...

    May 1, 2009, 00:00

  • PND37 ANTIPSYCHOTIC DRUG USE IN PATIENTS WITH ALZHEIMERS DISEASE TREATED WITH RIVASTIGMINE VERSUS DONEPEZIL- EVIDENCE FROM HEALTH CLAIMS DATA

    May 1, 2009, 00:00

  • PMH43 UNINTENDED CONSEQUENCES OF CURRENT ANTIDEPRESSANT USE IN A GERIATRIC POPULATION- THE BURDEN OF SIDE-EFFECTS ON ADHERENCE AND COSTS

    May 1, 2009, 00:00

  • Abstracts Index

    May 1, 2009, 00:00

  • RA4 METABOLIC SYNDROME RISK FACTORS FOR NATIVE BORN AND FIRST GENERATION ADOLESCENTS (12-17) IN THE UNITED STATES

    May 1, 2009, 00:00

  • PIN34 DOES COMBINING ANTIRETROVIRAL AGENTS IN TO A SINGLE DOSAGE FORM (CO-FORMULATIONS) ENHANCE QUALITY OF LIFE OF HIV/AIDS PATIENTS-A COST UTILITY STUDY

    May 1, 2009, 00:00

  • PHP35 THE EFFECT OF THE WITHDRAWAL OF HOSPITAL DAILY FEE ON THE NUMBER OF ADMISSIONS TO ACUTE CARE HOSPITAL WARDS IN HUNGARY

    May 1, 2009, 00:00

  • PIN55 VALIDATING LIKERT-TYPE MEASURES USING NONPARAMETRIC AND PARAMETRIC ITEM RESPONSE THEORY

    May 1, 2009, 00:00

  • PMS49 DRUG COVERAGE, UTILIZATION AND HEALTH AMONG ELDERLY PATIENTS WITH ARTHRITIS

    May 1, 2009, 00:00

  • PCN36 THE ESTIMATED IMPACT OF IN VITRO BIOMARKERS ON THE COSTEFFECTIVENESS OF POPULATION-WIDE COLORECTAL CANCER SCREENING

    May 1, 2009, 00:00

  • PGI1 A SYSTEMATIC REVIEW ON KUSHENIN VERSUS WESTERN MEDICINES FOR PATIENTS WITH CHRONIC HEPATITIS B

    May 1, 2009, 00:00

  • PIN17 COST EFFECTIVE FOR HPV VACCINE

    May 1, 2009, 00:00

  • CN1 RECENT ERYTHROPOIESIS-STIMULATING AGENT (ESA) UTILIZATION TREND IN CANCER CHEMOTHERAPY PATIENTS IN A MANAGED CARE AND A HOSPITAL OUTPATIENT SETTING

    May 1, 2009, 00:00

  • PMS51 RETROSPECTIVE ANALYSIS OF INFLIXIMAB DOSING AND INFUSION PATTERNS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A COMMERCIALLY-INSURED POPULATION

    May 1, 2009, 00:00

  • PMS31 CLINICAL AND ECONOMIC CHARACTERISTICS OF PATIENTS WITH FIBROMYALGIA

    May 1, 2009, 00:00

  • PIH17 COST/EFFECTIVENESS STUDY OF CLOMIPHENE CITRATE VERSUS ANASTROZOLE IN THE INDUCTION OF OVULATION IN BARREN ADULT PATIENTS AT A MEXICAN PUBLIC HOSPITAL

    May 1, 2009, 00:00

  • PCV80 MEDICATION ADHERENCE AND CARDIOVASCULAR DISEASE-RELATED HEALTH CARE RESOURCE UTILIZATION AMONG PATIENTS TREATED WITH FIXED DOSE COMBINATION VERSUS MULTI-PILL COMBINATION THERAPIES AMONG PATIENTS WITH DYSLIPIDEMIA IN A MANAGED CARE POP ...

    May 1, 2009, 00:00

  • PMH12 A META-ANALYSIS OF EFFICACY AND SAFETY OF PREGABALIN AND CLONAZEPAM IN THE TREATMENT OF ANXIETY DISORDERS

    May 1, 2009, 00:00

  • PMH9 ADULT ADHD IN THE UNITED STATES- A COMPARISON OF 2 METHODS TO ESTIMATE PREVALENCE

    May 1, 2009, 00:00

  • PIH46 OUTCOMES AND COSTS ASSOCIATED WITH FERTILITY DRUG THERAPY IN AN INSURED POPULATION WITH A STATE FERTILITY MANDATE

    May 1, 2009, 00:00

  • PMC39 A TRANSMISSION-DYNAMIC MODEL TO PREDICT THE INDIRECT BENEFITS OF INFANT VACCINATION WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV7) TO OLDER POPULATIONS

    May 1, 2009, 00:00

  • PDB35 MEDICATION NON-ADHERENCE AND NON-PERSISTENCE IN A MANAGED CARE DIABETES MELLITUS POPULATION

    May 1, 2009, 00:00

  • DB2 ANTI-HYPERTENSIVE DRUG USE AND RISK OF DEMENTIA IN PATIENTS WITH DIABETES MELLITUS (DM)

    May 1, 2009, 00:00

  • PND18 A HEALTH ECONOMIC EVALUATION OF TRANSANAL COLONIC IRRIGATION IN SPINAL CORD INJURY PATIENTS

    May 1, 2009, 00:00

  • PIN27 COST ANALYSIS OF THE MASS VACCINATION CAMPAIGN AGAINST HEPATITIS B IN ADOLESCENTS IN IRAN

    May 1, 2009, 00:00

  • PHP20 A PROGRAM EVALUATION OF A POLYPHARMACY SUB-POPULATION- MEDICATIONS, EMERGENCY ROOM VISITS, AND HOSPITALIZATIONS

    May 1, 2009, 00:00

  • PDB59 EFFECT OF CAPITATED MEDICAID HEALTH PLANS ON MEDICATION ADHERENCE AND HEALTH CARE SERVICE UTILIZATIONS IN TYPE-2 DIABETES

    May 1, 2009, 00:00

  • PCV74 PREDICTED REDUCTION IN HOSPITAL DAYS AND ASSOCIATED COSTS AMONG MANAGED CARE PRIMARY AND SECONDARY RISK MIXED DYSLIPIDEMIA PATIENTS TREATED WITH FIXED DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN COMBINATION THERAPY

    May 1, 2009, 00:00

  • MD7 DOES MEDICARE HAVE AN IMPLICIT COST-EFFECTIVENESS THRESHOLD?

    May 1, 2009, 00:00

  • PCN63 DIFFERENT TREATMENT PATTERNS COSTS IN METASTATIC BREAST CANCER (MBC) EXPOSED TO ANTHRACYCLINHES AND TAXANES (AT) IN 3 DIFFERENT MEXICAN PUBLIC HOSPITALS

    May 1, 2009, 00:00

  • PMS17 NATIONAL COST OF ILLNESS STUDY COMPARING VETERAN PATIENTS WITH GOUT TO THOSE WITH DIFFICULT TO MANAGE GOUT

    May 1, 2009, 00:00

  • PHP56 COMPRISON OF NOTIFIABLE DISEASES SURVELLIANCE WEBSITES OF FOUR COUNTRIES

    May 1, 2009, 00:00

  • PSS19 DEVELOPMENT AND VALIDATION OF PATIENT-REPORTED OUTCOMES (PRO) TOOL FOR EYELASH CHARACTERISTICS

    May 1, 2009, 00:00

  • PIN53 HEALTH CARE UTILIZATION OF ANTIBIOTICS WITHIN THE SLOVAK REPUBLIC

    May 1, 2009, 00:00

  • ND1 COST-EFFECTIVENESS OF DISEASE-MODIFYING THERAPY FOR MULTIPLE SCLEROSIS- A POPULATION-BASED EVALUATION

    May 1, 2009, 00:00

  • PRS24 INCREMENTAL ASTHMA-RELATED EXPENDITURES ASSOCIATED WITH HIGH UTILIZATION OF SHORT ACTING b-AGONISTS AMONG A COMMERCIALLY INSURED ASTHMATIC POPULATION IN THE U.S.

    May 1, 2009, 00:00

  • PMC90 MANAGING STUDY PARTICIPANT RECRUITMENT SITES- METHODS FOR OPTIMIZING SUBJECT RECRUITMENT AND RETENTION THROUGH PRIVATE PRACTICE OFFICES

    May 1, 2009, 00:00

  • PIH25 DIRECT COST OF INFERTILITY TREATMENT IN TURKEY

    May 1, 2009, 00:00

  • PHP23 DRUG USE AND EXPENDITURES FOR PART D ENROLLED SENIORS WHO REACHED THE COVERAGE GAP IN 2007

    May 1, 2009, 00:00

  • PIH33 LONGITUDINAL VALIDATION OF THE PREMENSTRUAL SYMPTOMS IMPACT SURVEY (PMSIS)

    May 1, 2009, 00:00

  • PDB5 SYSTEMATIC REVIEW IN TYPE-2 DIABETES - WHAT IS THE INFLUENCE OF LIFESTYLE CHANGE?

    May 1, 2009, 00:00

  • DU4 THE IMPACT OF DEMOGRAPHICS AND INSURANCE ON QUALITY OF CARE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN A CALIFORNIA MEDICAID PROGRAM

    May 1, 2009, 00:00

  • QL2 DEVELOPMENT OF AN ITEM BANK FOR A COMPUTER ADAPTIVE MEASURE OF FUNCTIONAL COGNITION FOR STROKE

    May 1, 2009, 00:00

  • PCN52 ECONOMIC EVALUATION OF FULVESTRANT (FASLODEX,) AS AN ADDITIONAL ENDOCRINE STEP IN THE TREATMENT SEQUENCE FOR HORMONE-RECEPTOR POSITIVE ADVANCED AND METASTATIC BREAST CANCER IN ISRAEL

    May 1, 2009, 00:00

  • PHP88 IDENTIFYING KEY DECISION PATHWAYS IN HEALTH TECHNOLOGY ASSESSMENT AROUND THE WORLD

    May 1, 2009, 00:00

  • PCV82 FRACTION OF NURSING HOME ADMISSION AND INCREMENTAL COST ATTRIBUTABLE TO NON ADHERENCE TO ANTI HYPERTENSIVE MEDICATIONS

    May 1, 2009, 00:00

  • PMC44 DEVELOPMENT OF AN INTERACTIVE MODEL TO EVALUATE THE ECONOMIC IMPACT OF CHD EVENTS AMONG ADULTS WITH DYSLIPIDEMIA FROM AN EMPLOYER PERSPECTIVE

    May 1, 2009, 00:00

  • PIN14 THE COST-EFFECTIVENESS OF TRUVADA, KIVEXA AND COMBIVIR IN THE TREATMENT OF ANTIRETROVIRAL NAVE HIV-1 INFECTED PATIENTS IN MEXICO

    May 1, 2009, 00:00

  • HT2 HEALTH TECHNOLOGY ASSESSMENT - A COMPREHENSIVE FRAMEWORK FOR EVIDENCE-BASED RECOMMENDATIONS IN ONTARIO

    May 1, 2009, 00:00

  • PMC23 WHERE IS THE CURRENT FOCUS OF HEALTH ECONOMICS? AN INVESTIGATION INTO THE PUBLISHED LITERATURE WITHIN THREE KEY HEALTH ECONOMICS JOURNALS

    May 1, 2009, 00:00

  • PMC54 ARE YOUNG CHILDREN ABLE TO MAKE TRADE-OFFS? A QUALITATIVE STUDY OF CHILDREN AGED 6 TO 12 YEARS AND THEIR PERCEPTIONS OF INFLUENZA VACCINATION

    May 1, 2009, 00:00

  • PCV88 EVALUATION OF COMPARATIVE EFFECTIVENESS- A MODEL FOR GENERATING HYPOTHESES AND DETERMINING SAMPLE SIZE

    May 1, 2009, 00:00

  • PCV53 A PHARMACOECONOMIC ANALYSIS OF PROPHYLAXIS THERAPIES AND TREATMENT OF VENOUS THROMBOEMBOLISM (VTE) IN MEXICAN PATIENTS WITH CANCER

    May 1, 2009, 00:00

  • PHP87 THE IMPACT OF THE SUBMISSION SEQUENCE - WHICH APPRAISING BODY TO SUBMIT TO FIRST?

    May 1, 2009, 00:00

  • PRS16 AN ECONOMIC EVALUATION OF A PHARMACOLOGICAL INTERVENTION USING VARENICLINE AS THERAPY FOR SMOKING CESSATION

    May 1, 2009, 00:00

  • PCV49 ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR THE NONINVASIVE MANAGEMENT OF PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES (NSTE-ACS)- THE PHARMACOECONOMIC EVALUATION IN RUSSIA

    May 1, 2009, 00:00

  • PSY20 COST-EFFECTIVENESS OF PROPHYLAXIS AGAINST ON-DEMAND TREATMENT IN BOYS WITH SEVERE HAEMOPHILIA IN IRAN

    May 1, 2009, 00:00

  • PCN6 USING PREDICTIVE MODELS TO ANALYZE LUNG CANCER DATA

    May 1, 2009, 00:00

  • PIH22 ESTIMATING DIRECT COST OF VAGINITIS IN TURKEY

    May 1, 2009, 00:00

  • PMC59 PSYCHOMETRIC ASSESSMENT OF AN INSTRUMENT TO MEASURE PATIENT SATISFACTION WITH MEDICATION THERAPY MANAGEMENT SERVICES

    May 1, 2009, 00:00

  • PCN81 HEALTH RELATED QUALITY OF LIFE IN THE DIFFERENT STAGES OF COLORECTAL CANCER IN PATIENTS ATTENDED IN THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2009, 00:00

  • DU1 PHYSICAL FUNCTION AND THE CONCOMITANT USE OF ANTICHOLINERGIC ANTIHISTAMINES AND CHOLINESTERASE INHIBITORS AMONG MEDICAID RECIPIENTS WITH DEMENTIA

    May 1, 2009, 00:00

  • CM1 ASSOCIATION BETWEEN INSURANCE GAPS AND ANTIHYPERTENSION MEDICATION ADHERENCE IN A NATIONAL REPRESENTATIVE SAMPLE IN THE UNITED STATES

    May 1, 2009, 00:00

  • PIH14 COST-EFFECTIVENESS OF NEONATAL SCREENING FOR CONGENITAL ERRORS OF METABOLISM USING TANDEM MASS SPECTROMETRY

    May 1, 2009, 00:00

  • PRS19 HOW MUCH WOULD AMERICA SAVE IF ASTHMA DID NOT EXIST?

    May 1, 2009, 00:00

  • PDB49 THE EFFECT OF READINESS TO CHANGE ON MEASURES OF DIABETES CONTROL AND ATTITUDES TOWARDS DIABETES

    May 1, 2009, 00:00

  • PCN49 COLORECTAL CANCER SCREENING FOR AVERAGE RISK INDIVIDUALS- AN ECONOMIC EVALUATION

    May 1, 2009, 00:00

  • PCN96 ESTIMATING THE TIME OF PRODUCTIVITY LOST OF PATIENTS WITH CANCER AND MUSCULAR-SKELETAL DISEASES IN SLOVAKIA

    May 1, 2009, 00:00

  • PM4 AN EXPLORATION OF THE POTENTIAL CLINICAL BENEFITS AND RISKS OF CYP2D6 TESTING TO GUIDE TAMOXIFEN THERAPY IN BREAST CANCER

    May 1, 2009, 00:00

  • PHP32 EQUITY AND ACCESS TO GENERIC DRUGS- A COMPARISON OF GENERIC DRUG DISCOUNT PROGRAMS OFFERED BY CHAIN PHARMACIES IN THE UNITED STATES

    May 1, 2009, 00:00

  • PDB51 ASSOCIATION BETWEEN MEDICATION ADHERENCE AND HBA1C LEVELS IN DIABETIC PARTICIPANTS ENROLLED IN A DISEASE MANAGEMENT PROGRAM

    May 1, 2009, 00:00

  • PHP47 PREDICTING HEALTH SERVICE UTILIZATION WITH THE PCS AND MCS OF THE SF-36

    May 1, 2009, 00:00

  • MD1 NONADHERENCE WITH ORAL HYPOGLYCEMICS AMONG MEDICARE PART D ENROLLEES WITH DIABETES

    May 1, 2009, 00:00

  • CO2 METHODS FOR INTERPRETING AND DISPLAYING RESULTS- FROM REGRESSION MODELS- BEYOND BETAS AND ODDS RATIOS

    May 1, 2009, 00:00

  • PCN27 COMPARING AND VALIDATING DIFFERENT TYPES OF PROPENSITY SCORE MATCHING TECHNIQUES

    May 1, 2009, 00:00

  • PIH40 ASSESSING WORK PRODUCTIVITY IMPAIRMENT IN PREMENSTRUAL SYNDROME AND PREMENSTRUAL DYSPHRORIC DISORDER

    May 1, 2009, 00:00

  • PRS18 THE ECONOMIC BURDEN OF CHRONIC OBSTRUCTION PULMONARY DISEASE DUE TO SMOKING

    May 1, 2009, 00:00

  • PCV42 INCREMENTAL COST-EFFECTIVENESS ANALYSIS OF ANGIOTENSIN RECEPTOR BLOCKERS IN HYPERTENSIVE PATIENTS IN A US MANAGED CARE POPULATION

    May 1, 2009, 00:00

  • PDB15 UTILIZATION PATTERNS AND HYPOGLYCEMIA IN PATIENTS WITH TYPE-2 DIABETES ON CONCOMITANT EXENATIDE AND LONG-ACTING INSULIN THERAPY

    May 1, 2009, 00:00

  • PDB23 ECONOMIC EVALUATION OF METFORMIN, METFORMIN SIBUTRAMIN OR ACARBOSE IN THE MANAGEMENT OF OVERWEIGHT AND OBESE DIABETES PATIENTS

    May 1, 2009, 00:00

  • PCV6 BURDEN OF HYPERLIPIDEMIA AND ASSOCIATED TREATMENT PATTERNS IN EUROPE- A COMPARISON OF FIVE COUNTRIES

    May 1, 2009, 00:00

  • PIN1 STATISTICAL ANALYSIS OF MONONUCLEOSIS IN ADOLESCENTS

    May 1, 2009, 00:00

  • PMC53 SHOULD AN SF-10 REPLACE THE SF-12?

    May 1, 2009, 00:00

  • PCASE1 CASE STUDY OF CREATING A FORMULARY MANAGEMENT PROCESS AT A COMPREHENSIVE CANCER CENTER IN BANGALORE, INDIA

    May 1, 2009, 00:00

  • UT3 THE VALUE OF ADDED LIFE YEARS AS A FUNCTION OF AGE, PROGNOSIS AND QUALITY OF LIFE

    May 1, 2009, 00:00

  • CM4 NONADHERENCE TO CLINICAL PRACTICE GUIDELINES FOR MULTIPLE DISEASE CONDITIONS IN A CALIFORNIA MEDICAID POPULATION

    May 1, 2009, 00:00

  • PCN20 THE BUDGETARY IMPACT OF PEMETREXED PLUS CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)

    May 1, 2009, 00:00

  • PRS28 TRENDS IN PREVALENCE OF OBESITY AND MEDICAL COSTS IN ASTHMA PATIENTS IN THE UNITED STATES

    May 1, 2009, 00:00

  • PMS26 CHARACTERISTICS AND HEALTH CARE UTILIZATION RESULTING FROM INJECTION SITE REACTIONS WITH ANTI-TNF TREATMENTS FOR RHEUMATOID ARTHRITIS- AN ANALYSIS OF CASES AT AN URBAN TEACHING HOSPITAL

    May 1, 2009, 00:00

  • PMC5 PRO AND UTILITY ASSESSMENT- ADDRESSING CONFOUNDS OF CHANGING SELF-REFERENCE

    May 1, 2009, 00:00

  • PMC72 ASSESSING ANXIETY AND DEPRESSION ON AN INTERNATIONAL LEVEL

    May 1, 2009, 00:00

  • PSY3 BURDEN OF OBESITY AND ASSOCIATED TREATMENT PATTERNS IN EUROPE- A COMPARISON OF FIVE COUNTRIES

    May 1, 2009, 00:00

  • PSS10 ECONOMIC BURDEN OF MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS IN CANADA

    May 1, 2009, 00:00

  • PCN82 HFS 14- A SPECIFIC QUALITY OF LIFE INSTRUMENT FOR PATIENTS WITH HAND-FOOT SYNDROME

    May 1, 2009, 00:00

  • PCV52 ECONOMIC EVALUATION OF DALTEPARIN FOR THE MANAGEMENT OF THROMBOEMBOLIC VENOUS DISEASE (VTE) AFTER TOTAL KNEE ARTHROPLASTY IN MEXICO

    May 1, 2009, 00:00

  • PMH78 HOSPITALIZATION RATES AMONG INDIVIDUALS WITH BIPOLAR DISORDER INITIATING THERAPY WITH ARIPIPRAZOLE OR QUETIAPINE

    May 1, 2009, 00:00

  • PCV89 DIABETES MANAGEMENT AND KNOWLEDGE IMPROVEMENTS AS A RESULT OF PATIENT EDUCATION- A COMMUNITY BASED, RANDOMIZED CLINICAL TRIAL

    May 1, 2009, 00:00

  • PGI8 COST-EFFECTIVENESS OF PEG-IFN ALPHA 2A OR 2B PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C IN MEXICO

    May 1, 2009, 00:00

  • PSY50 REVENUES FROM VENDED BEVERAGES IN WEST VIRGINIA PUBLIC SCHOOLS

    May 1, 2009, 00:00

  • PCV57 HEALTH ECONOMIC EVALUATION OF CONTRAST MEDIA IN CORONAROGRAPHY- ISO-OSMOLAR IODIXANOL VS. LOW-OSMOLAR MEDIA

    May 1, 2009, 00:00

  • PUK3 CALCIUM-BASED PHOSPHATE BINDERS LEAD TO INCREASED PROGRESSION OF VASCULAR CALCIFICATION IN CHRONIC KIDNEY DISEASE

    May 1, 2009, 00:00

  • PMS50 A PRELIMINARY ANALYSIS OF BIOLOGICS MEDICATION-TAKING BEHAVIOR AMONG RHEUMATOID ARTHRITIS PATIENTS

    May 1, 2009, 00:00

  • PMC75 MEANINGFUL VERSUS USEABLE RESPONSES TO PREFERENCE SURVEYS- INSIGHTS INTO IMPROVING THE VALIDITY OF HEALTH UTILITY SCORES

    May 1, 2009, 00:00

  • PCV66 INPATIENT RESOURCE USE AMONG PATIENTS TREATED FOR PRIMARY ATRIAL FIBRILLATION (AF)- ROLE OF CLINICAL FACTORS AND CHOICE OF INITIAL CONVERSION THERAPY

    May 1, 2009, 00:00

  • PSY52 ESTIMATION OF CLINICAL AND ECONOMIC IMPACT OF CHRONIC PAIN ON THE BENEFICIARIES OF A PRIVATE HEALTH PLAN IN BRAZIL

    May 1, 2009, 00:00

  • PHP5 MARKET SHARE OF INTENSIVE CARE UNITS IN HUNGARY ACCORDING TO THE DRG SYSTEM

    May 1, 2009, 00:00

  • PCV110 DO CANADIAN PHYSICIANS CORRECTLY IDENTIFY HIGH RISK CV PATIENTS?

    May 1, 2009, 00:00

  • PMC64 DEVELOPMENT OF A CHECKLIST TO ASSESS THE QUALITY OF TRANSLATIONS OF PATIENT-REPORTED OUTCOMES (PRO) INSTRUMENTS

    May 1, 2009, 00:00

  • PMC76 AN ASSESSMENT OF THE EVIDENCE TO SUPPORT THE USE OF LINGUISTIC VALIDATION INTERVIEWS AS AN INTEGRAL PART OF THE TRANSLATION OF PROS FOR USE IN MULTI-NATIONAL TRIALS

    May 1, 2009, 00:00

  • PMS41 AN ASSESSMENT OF SELF REPORTED OUTCOMES IN A NATIONALLY REPRESENTATIVE SAMPLE OF ELDERLY PERSON DIAGNOSED WITH RHEUMATOID ARTHRITIS

    May 1, 2009, 00:00

  • PCV68 ADMINISTRATIVE CLAIMS IN A LARGE BRAZILIAN NATIONWIDE DATABASE- A DESCRIPTIVE ANALYSIS OF THE DIRECT MEDICAL COSTS OF CORONARY ARTERY BYPASS GRAFTING (CABG) AMONG DIFFERENT REGIONS IN A CONTINENTAL-SIZE COUNTRY

    May 1, 2009, 00:00

  • PDB64 A REVIEW OF RETROSPECTIVE, CONTINUOUS GLUCOSE MONITORING- AN EXAMPLE OF A MEDICAL DEVICE WHERE THE TYPICAL PRIMARY OUTCOME MEASURE MAY BE INAPPROPRIATE?

    May 1, 2009, 00:00

  • PSY16 A CANADIAN BASED PHARMACOECONOMIC ANALYSIS OF SELECTED ANTICONVULSANTS, SNRIS AND TCAS IN TREATING NEUROPATHIC PAIN

    May 1, 2009, 00:00

  • PDB47 THE ASSOCIATION BETWEEN PATIENT-REPORTED DIABETES SYMPTOMS AND TOLERABILITY ISSUES OF ORAL ANTIDIABETIC AGENTS ON WORK AND LIFE PRODUCTIVITY

    May 1, 2009, 00:00

  • PIH1 ASSESSMENT OF LENGTH OF STAY FOR WOMEN WITH HIGH RISK COMORBIDITIES DURING LABOR AND DELIVERY

    May 1, 2009, 00:00

  • PMH18 HEALTH CARE RESOURCE UTILIZATION ANALYSIS OF PRE/POST LONG-ACTING RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDERS IN THREE REGIONAL PUBLIC HOSPITALS IN HONG KONG

    May 1, 2009, 00:00

  • PCV9 COMPARATIVE EFFECTIVENESS OF INDIVIDUAL ANGIOTENSINCONVERTING ENZYME INHIBITORS IN PATIENTS WITH CHRONIC HEART FAILURE

    May 1, 2009, 00:00

  • PIH15 COST EFFECTIVENESS ANALYSIS OF GOSERELIN EMPIRIC THERAPY FOR DEEP ENDOMETRIOSIS TREATMENT

    May 1, 2009, 00:00

  • PMC25 A SYSTEMATIC REVIEW OF BURDEN OF DISEASE STUDIES IN THE ASIA-PACIFIC REGION

    May 1, 2009, 00:00

  • PND16 ECONOMIC IMPACT OF DISEASE-MODIFYING THERAPIES IN MULTIPLE SCLEROSIS PATIENTS IN A MANAGED CARE SETTING

    May 1, 2009, 00:00

  • PIN2 FACTORS INFLUENCING PEDIATRIC PATIENTS WITH PNEUMONIA

    May 1, 2009, 00:00

  • PND23 PREVALENCE OF TREATMENT GAPS IN MULTIPLE SCLEROSIS PATIENTS RECEIVING DISEASE-MODIFYING DRUGS- FINDINGS FROM A NATIONAL MANAGED CARE DATABASE

    May 1, 2009, 00:00

  • PSS6 AN ECONOMIC ANALYSIS TO EVALUATE ANTI-GLAUCOMA PHARMACOTHERAPY

    May 1, 2009, 00:00

  • PRS44 QUALITY OF LIFE EVALUATION OF PATIENTS WITH NONTRANSMISSIBLE CHRONIC DISEASES ENROLLED IN A PHARMACY BENEFIT MANAGEMENT

    May 1, 2009, 00:00

  • PIH30 PATTERNS OF UTILIZATION AND DISCONTINUATION OF MEDICATION IN A RETIREE POPULATION

    May 1, 2009, 00:00

  • MO2 A SYSTEMATIC EVALUATION OF EMPIRICAL BAYES METHODS UNDER TIME CENSORED CONDITIONS

    May 1, 2009, 00:00

  • PDB60 ASSESSMENT OF THE INTERVAL BETWEEN FIRST EXENATIDE CLAIM AND LAST PRIOR ORAL ANTIDIABETIC CLAIM

    May 1, 2009, 00:00

  • PCN104 HEALTH WORKERS WORK ENVIRONMENT SATISFACTION IN ONCOLOGIC SERVICES AT THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2009, 00:00

  • PDB11 EFFECT OF ACE INHIBITORS AND ARBS ON INCIDENCE OF RENAL DISEASE IN ELDERLY PATIENTS WITH DIABETES

    May 1, 2009, 00:00

  • PCN5 GAINS ASSOCIATED WITH CLINICAL EXAMS AND MAMMOGRAPHIC SCREENING FOR WOMEN ABOVE 40 YEARS OF AGE

    May 1, 2009, 00:00

  • PSY17 DECISION-ANALYTIC MODELLING OF TREATMENT OPTIONS FOR PATIENTS WITH SEVERE HAEMOPHILIA A AND INHIBITORS IN GERMANY

    May 1, 2009, 00:00

  • PIH31 ASSESSING THE VALUE OF LESS FREQUENT MEDICATION DOSING ON ADHERENCE AND OUTCOMES

    May 1, 2009, 00:00

  • PMS4 RISK FACTORS FOR INCIDENT GOUT AMONG WOMEN- A PROSPECTIVE STUDY

    May 1, 2009, 00:00

  • PRS32 ADJUSTING THE NICOTINE DOSE- THE KEY TO A SUCCESSFUL, 'TAILORED' METHOD OF QUITTING SMOKING

    May 1, 2009, 00:00

  • PMC50 REGRESSION ESTIMATORS FOR QUALITY OF LIFE AND QUALITYADJUSTED LIFE YEARS (QALYS)

    May 1, 2009, 00:00

  • PCN16 COST OF MANAGING SIDE EFFECTS OF FIRST-LINE BEVACIZUMAB (BEV) LOWER-DOSE INTERFERON-ALPHA2A IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN GERMANY, FRANCE, AND UNITED KINGDOM

    May 1, 2009, 00:00

  • PSY42 USTEKINUMAB REDUCES ITCH, BODILY PAIN, AND FATIGUE IN PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS

    May 1, 2009, 00:00

  • MD8 OUT OF POCKET PSYCHOTROPIC PRESCRIPTION BURDEN ON ELDERLY MEDICARE BENEFICIARIES BEFORE AND AFTER THE IMPLEMENTATION OF MEDICARE PART D

    May 1, 2009, 00:00

  • PSY40 FEASIBILITY OF DAILY DIARIES WITH QOL ASSESSMENT IN CONGENTIAL HEMOPHILIA PATIENTS WITH ALLOANTIBODY INHIBITORS

    May 1, 2009, 00:00

  • PHP71 HOW DO MANAGED PHYSICIAN PANELS COMPARE AGAINST NON-PANEL PHYSICIANS FOR THE PURPOSE OF RESEARCH?

    May 1, 2009, 00:00

  • PCV34 FINANCIAL ASSESSMENT OF A COMPREHENSIVE CARDIAC CARE PROGRAM FOR PATIENTS WITH OCCULSIVE CORONARY ARTERY DISEASE

    May 1, 2009, 00:00

  • PDB36 IMPACT OF TREATMENT COMPLEXITY ON ADHERENCE AND GLYCEMIC CONTROL- AN ANALYSIS OF ORAL ANTI-DIABETIC AGENTS

    May 1, 2009, 00:00

  • RA3 A BAYESIAN DECISION-ANALYTIC ECONOMIC MODEL TO OPTIMIZE ALLOCATION OF RISK IN PAY-FOR-PERFORMANCE PAYMENT ARRANGEMENTS

    May 1, 2009, 00:00

  • PIN30 ACUTE CARE COSTS OF GRAM-NEGATIVE PNEUMONIA IN THE UNITED STATES- A HEALTH CARE COST AND UTILIZATION PROJECT (HCUP) DATA ANALYSIS

    May 1, 2009, 00:00

  • PCV106 CREATING A QUALITY INDEX TO RANK HOSPITALS

    May 1, 2009, 00:00

  • PCV58 TRIAL-BASED ECONOMIC EVALUATION ALONGSIDE THE TCYB (TAKE CONTROL OF YOUR BLOOD PRESSURE) TRIAL

    May 1, 2009, 00:00

  • PIH38 STATISTICAL ANALYSES OF FACTORS AFFECTING LENGTH OG STAY AND TOTAL CHARGES FOR PEDIATRIC PATIENTS AFFLICTED WITH PERINATAL INFECTION

    May 1, 2009, 00:00

  • PMH85 PATTERNS OF AUGMENTATION OF EXTENDED-RELEASE STIMULANTS FOR ADHD WITH IMMEDIATE-RELEASE STIMULANTS IN CHILDREN AND ADOLESCENTS

    May 1, 2009, 00:00

  • PMC46 A REVIEW OF THE EVOLUTION OF HEALTH ECONOMIC MODELS OF SMOKING CESSATION

    May 1, 2009, 00:00

  • PMC38 VALIDATION OF THE IHE/JJ ECONOMIC SIMULATION MODEL OF TYPE-2 DIABETES MELLITUS (T2DM)

    May 1, 2009, 00:00

  • PIN5 PHARMACOGENOMICS- APPLICABILITY IN ANTIRETRO VIRAL THERAPY (ART) IN HIV PATIENTS

    May 1, 2009, 00:00

  • PCN61 THE ECONOMIC BURDEN OF METASTATIC BREAST CANCER

    May 1, 2009, 00:00

  • DISCLOSURE INFORMATION

    May 1, 2009, 00:00

  • PIH42 WORK DISABILITY AND RETIREMENT IN DUAL-EARNER FAMILIES

    May 1, 2009, 00:00

  • RA1 CAN THE PUBLICS RISK/BENEFIT BE TRUSTED?

    May 1, 2009, 00:00

  • PMH41 ADHERENCE AND PERSISTENCE TO SECOND-GENERATION ATYPICAL ANTIPSYCHOTIC MEDICATIONS IN PATIENTS ENROLLED IN EMPLOYER-SPONSORED HEALTH PLANS

    May 1, 2009, 00:00

  • QL4 VALIDATION OF THE TREATMENT RELATED IMPACT MEASURE FOR DIABETES TREATMENT AND DEVICE; TRIMXD -DIABETES AND TRIM-DIABETES DEVICE

    May 1, 2009, 00:00

  • PHP45 VARIABILITY OF FEES IN THE FIELD OF PHYSICAL THERAPY IN THE AUSTRIAN CONTRACT PHYSICIANS SECTOR

    May 1, 2009, 00:00

  • PMS32 HIGHER OUT-OF-POCKET PHARMACY EXPENSE IS ASSOCIATED WITH HIGHER SWITCHING RATES AMONG ANTI-TUMOR NECROSIS FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2009, 00:00

  • PCV22 VARIATION OF SEASONAL, WEEKLY AND DAILY RHYTHM OF ACUTE MYOCARDIAL INFARCTION IN DIABETIC PATIENTS

    May 1, 2009, 00:00

  • DB3 DIRECT AND INDIRECT COSTS ASSOCIATED WITH DIABETES PATIENTS WITH AND WITHOUT MACROVASCULAR COMORBIDITIES IN THE UNITED STATES

    May 1, 2009, 00:00

  • PMS2 GOUT AND THE RISK OF ACUTE MYOCARDIAL INFARCTION AMONG ELDERLY WOMEN

    May 1, 2009, 00:00

  • PIN37 SELF-REPORTED PILL BURDEN AS A PREDICTOR FOR ADHERENCE IN HIV-INFECTED PATIENTS

    May 1, 2009, 00:00

  • PCN30 THE COSTS OF TREATING PATIENTS WITH ADVANCED OR RECURRENT NON-SMALL CELL CANCER (NSCLC) WITH BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE COMPARED WITH PEMETREXED PLUS CISPLATIN IN INDUCTION AND MAINTENANCE THERAPY IN GERMANY AND ITALY

    May 1, 2009, 00:00

  • PND3 PREVALENCE OF ALZHEIMERS DISEASE AND RELATED DEMENTIA AND THE CO-EXISTING CONDITIONS IN MANAGED CARE ORGANIZATIONS

    May 1, 2009, 00:00

  • PCN93 ONCOLOGIC PATIENT SATISFACTION IN ONCOLOGIC SERVICES IN A TERTIARY REFERRAL CENTER AT THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2009, 00:00

  • PMC61 MEASURING POPULATION HEALTH STATUS USING EQ-5D- RESULTS FROM THE HEALTH SURVEY FOR ENGLAND 1996-2006

    May 1, 2009, 00:00

  • PIH51 RACIAL/ETHNIC DISPARITIES IN PRESCRIPTION DRUG USE AMONG OLDER ADULTS IN THE UNITED STATES

    May 1, 2009, 00:00

  • PRS17 A COST-CONSEQUENCE ANALYSIS COMPARING AN ESTABLISHED AND A NOVEL EPINEPHRINE AUTO-INJECTOR FOR ANAPHYLAXIS

    May 1, 2009, 00:00

  • PMH21 COST-EFFECTIVENESS OF OLANZAPINE LONG-ACTING INJECTION IN THE TREATMENT OF NON-ADHERENCE PATIENTS WITH SCHIZOPHRENIA IN THE UNITED STATES

    May 1, 2009, 00:00

  • PRS31 ASSOCIATION BETWEEN COMPLIANCE AND RESPIRATORY-RELATED COSTS FOR PATIENTS WITH COPD TREATED WITH MAINTENANCE THERAPY

    May 1, 2009, 00:00

  • PCN87 TEST-RETEST RELIABILITY OF AN INTERACTIVE VOICE RESPONSE (IVR) VERSION OF THE EORTC QLQ-C30

    May 1, 2009, 00:00

  • PRS2 DOES ADD-ON EVENING DOSE OF FORMOTEROL IMPROVE LUNG FUNCTION FOR COPD PATIENTS RECEIVING FIXED-DOSE OF TIOTROPIUM AND FORMOTEROL?

    May 1, 2009, 00:00

  • PSY5 THE USEFULNESS OF REGISTRY DATA FOR UNDERSTANDING TREATMENT PRACTICES AND CLINICAL OUTCOMES IN HEMOPHILIA- THE EXPERIENCE OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY (2004-2008)

    May 1, 2009, 00:00

  • PCN7 CLINICAL AND ECONOMIC OUTCOMES IN CANCER CHEMOTHERAPY PATIENTS INITIATED ON ERYTHROPOIESIS STIMULATING AGENTS (ESA) AT HEMOGLOBIN (HB) LEVELS 10 G/DL

    May 1, 2009, 00:00

  • PDB58 NONADHERENCE TO ORAL HYPOGLYCEMIC AGENTS AND POTENTIALLY AVOIDABLE HOSPITALIZATIONS- AN EXAMINATION OF THE MEDICARE PART D PATIENTS WITH DIABETES

    May 1, 2009, 00:00

  • PCN37 AN ECONOMIC EVALUATION OF CIRCULATING TUMOR CELLS DETECTION IN METASTATIC BREAST CANCER

    May 1, 2009, 00:00

  • PIH2 CLINICAL AND COST OUTCOMES AMONG PATIENTS ON WARFARIN WITH ELECTRONIC ALERTS TO REMIND PROVIDERS ABOUT HIGH INTERNATIONAL NORMALIZED RATIO

    May 1, 2009, 00:00

  • HM4 THE IMPACT OF A PHARMACIST-PROVIDED TELEPHONE MEDICATION THERAPY MANAGEMENT PROGRAM ON MEDICATION AND HEALTH-RELATED PROBLEMS, MEDICATION ADHERENCE, AND TOTAL DRUG COSTS AMONG MEDICARE BENEFICIARIES- A 6-MONTH FOLLOW-UP

    May 1, 2009, 00:00

  • PHP28 TRENDS IN BEERS DRUG USE IN THE DUALLY ELIGIBLE MEDICARE AND MEDICAID POPULATION USING THE 1997 BEERS DRUG LIST FROM 1999 THROUGH 2004

    May 1, 2009, 00:00

  • PSY14 TOLERABILITY OF INTRAVENOUSLY ADMINISTERED IMMUNE GLOBULIN IN THE HOME SETTING

    May 1, 2009, 00:00

  • PCV72 COST-EFFECTIVENESS ANALYSIS OF ADD-ON ALISKIREN TO LOSARTAN TREATMENT FOR PATIENTS WITH TYPE 2 DIABETES, HYPERTENSION AND NEPHROPATHY IN THE CZECH PATIENTS FROM PAYOR PERSPECTIVE

    May 1, 2009, 00:00

  • PCV65 MANAGEMENT OF PRIMARY ATRIAL FIBRILLATION (AF)- PATIENT CHARACTERISTICS AND HOSPITAL CARE SETTING

    May 1, 2009, 00:00

  • PDB18 A BUDGET IMPACT MODEL (BIM) TO ASSESS THE IMPACT ON THE ITALIAN NATIONAL HEALTH SERVICE (INHS) BUDGET OF THE INTRODUCTION OF MIMPARA (CINACALCET) IN THE NEW INDICATION PRIMARY HYPERPARATIROIDISM (PHPT)

    May 1, 2009, 00:00

  • CM2 UTILIZATION AND PERSISTENCE OF ALISKIREN IN A REAL-WORLD ENVIRONMENT

    May 1, 2009, 00:00

  • PIN12 COST-EFFECTIVENESS ANALYSIS OF DAPTOMYCIN VERSUS VANCOMYCIN IN COMPLICATED SKIN AND SOFT STRUCTURE INFECTION (CSSSI) USING A DECISION ANALYTIC MODEL

    May 1, 2009, 00:00

  • PMH34 TREATMENT BURDEN AND COSTS OF LISDEXAMFETAMINE DIMESYLATE USERS COMPARED WITH USERS OF OTHER LONGACTING TREATMENTS IN PATIENTS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER

    May 1, 2009, 00:00

  • PDB19 ECONOMIC EVALUATION OF LONG TERM SOMATOSTATIN ANALOGS IN THE TREATMENT OF ACROMEGALY IN MEXICO- MONOTHERAPY VS SEQUENTIAL THERAPY

    May 1, 2009, 00:00

  • PGI5 PUBLISHED COST-EFFECTIVENESS RESULTS FOR CHRONIC HEPATITIS B AND C-A COMPARATIVE ANALYSIS

    May 1, 2009, 00:00

  • PCV14 CLINICAL AND ECONOMIC OUTCOMES IN PATIENTS SWITCHED TO SIMVASTATIN IN A COMMUNITY-BASED PRIMARY CARE SETTING

    May 1, 2009, 00:00

  • PCV45 ECONOMIC ANALYSIS OF THE INSERTABLE CARDIAC MONITOR IN DIAGNOSIS OF SYNCOPE COMPARED TO CONVENTIONAL DIAGNOSTICS- A CANADIAN PERSPECTIVE

    May 1, 2009, 00:00

  • PMH67 ORAL SUPPLEMENTATION AND CONCOMITANT MEDICATION IN THE TREATMENT OF SCHIZOPHRENIA WITH LONG-ACTING ATYPICAL ANTIPSYCHOTICS

    May 1, 2009, 00:00

  • PMH64 MEASUREMENTS OF ADHERENCE TO ANTI-DEPRESSANT MEDICATIONS

    May 1, 2009, 00:00

  • PMH73 DISCREPANCIES BETWEEN KNOWLEDGE, ATTITUDES AND BELIEFS AND THE ACTUAL PRACTICE (KABP) OF PHYSICIANS WHO CARE FOR PATIENTS WITH DEPRESSION AND/OR BIPOLAR DISORDER

    May 1, 2009, 00:00

  • PMH61 THE EFFECTS OF ANTIDEPRESSANT STEP-THERAPY PROTOCOLS ON PHARMACEUTICAL AND MEDICAL UTILIZATION AND EXPENDITURES

    May 1, 2009, 00:00

  • PHP42 REVIEW OF THE FINANCIAL MECHANISM OF SUDAN HEALTH SYSTEM

    May 1, 2009, 00:00

  • PSS12 COST-UTILITY ANALYSIS OF POSTERIOR LAMELLAR KERATOPLASTY IN CANADA

    May 1, 2009, 00:00

  • PRS1 SMOKING CESSATION AND ITS PREDICTORS- RESULTS FROM COMMUNITY BASED PHARMACY TOBACCO CESSATION PROGRAM IN NEW MEXICO

    May 1, 2009, 00:00

  • PHP41 POCKET EXPENSES IN HEALTH IN COLOMBIA PER INCOME, 1997-2003

    May 1, 2009, 00:00

  • PCN15 ENDOMETRIAL CARCINOMA RISK OF VAGINAL ESTROGEN IN MEDICAID WOMEN WITH ATROPHIC VAGINITIS

    May 1, 2009, 00:00

  • PCV35 PHARMACOECONOMIC MODEL OF ENOXAPARIN VERSUS HEPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM IN MEDICAL PATIENTS

    May 1, 2009, 00:00

  • MD3 EFFECT OF LIPID LOWERING DRUG USE ON HOSPITALIZATIONS, EMERGENCY ROOM VISITS, AND MORTALITY IN MEDICARE DIABETIC POPULATION

    May 1, 2009, 00:00

  • PND10 COST-EFFECTIVENESS STUDY IN PATIENTS WITH MILD TO MODERATELY SEVERE ALZHEIMERS DISEASE- PROJECTED BENEFITS OF DONEPEZIL IN THE UNITED KINGDOM

    May 1, 2009, 00:00

  • PCN47 COST-EFFECTIVENESS OF DIFFERENT TREATMENTS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA- A RETROSPECTIVE STUDY

    May 1, 2009, 00:00

  • PIH24 AN INVESTIGATION OF THE EFFECTS OF GENDER, RACE, AGE, AND OTHER DESCRIPTIVE VARIABLES ON THE LENGTH OF HOSPITALIZATION AND TOTAL HOSPITALIZATION CHARGES ACCRUED BY PEDIATRIC INPATIENTS AFFLICTED WITH PHARYNGITIS

    May 1, 2009, 00:00

  • PMC52 CULTURAL ADAPTATION AND VALIDATION OF A HEATH RELATED QUALITY OF LIFE QUESTIONNAIRE- FUNCTIONAL OUTCOMES OF SLEEP QUESTIONNAIRE

    May 1, 2009, 00:00

  • PCV24 DAILY ALCOHOL CONSUMPTION AND RACE/ETHNICITY- THEIR RELATIONSHIP TO STROKE OR CORONARY ARTERY DISEASE IN THE US ADULT POPULATION

    May 1, 2009, 00:00

  • PHP86 PUBLICATION TRENDS OF BUDGET IMPACT ANALYSES OVER THE PAST SIX YEARS

    May 1, 2009, 00:00

  • DB1 PROJECTED COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 IN TYPE 2 DIABETES PATIENTS SWITCHED FROM BIPHASIC HUMAN INSULIN IN THE UNITED STATES

    May 1, 2009, 00:00

  • PMS24 LOWER HIP FRACTURE RATES IN THE FIRST YEAR OF THERAPY TRANSLATE INTO FAVORABLE COST-EFFECTIVENESS FOR RISEDRONATE VS. GENERIC ALENDRONATE AMONG HIGH RISK PATIENTS

    May 1, 2009, 00:00

  • PCV62 IDENTIFYING DRIVERS OF POST-HOSPITAL DISCHARGE FOR PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) USING QUANTILE REGRESSIONS

    May 1, 2009, 00:00

  • PCV29 RANDOMISED, FLEXIBLE DOSE STUDY TO COMPARE THE EFFICACY AND SAFETY OF NIFEDIPINE SUSTAINED RELEASE WITH GINGKGO BILOBA EXTRACT TO TREAT PATIENTS WITH PRIMARY RAYNAUD KOREAN RAYNAUD (KOARA) STUDY

    May 1, 2009, 00:00

  • PDB31 LONG-TERM OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES RECEIVING GLIMEPIRIDE COMBINED WITH LIRAGLUTIDE OR ROSIGLITAZONE

    May 1, 2009, 00:00

  • ND3 PRESCRIBING PATTERNS AMONG DEMENTIA PATIENTS AT THE VETERANS AFFAIRS MARYLAND HEALTH CARE SYSTEM (VAMHCS)

    May 1, 2009, 00:00

  • PMH58 OUTCOMES ASSESSMENT OF AN ANTIPSYCHOTIC DRUG ALGORITHM- EFFECTS OF THE MISSISSIPPI STATE HOSPITAL ALGORITHM PROJECT

    May 1, 2009, 00:00

  • PCN111 INFLUENCE OF AGE ON COMORBIDITIES AND TREATMENT IN PATIENTS WITH RENAL CELL CARCINOMA (RCC)- A RETROSPECTIVE CLAIMS DATABASE ANALYSIS

    May 1, 2009, 00:00

  • PGI9 ECONOMIC ANALYSIS OF THE POTENTIAL USAGES OF ALVIMOPAN AND METHYLNALTREXONE AT A TERTIARY CANCER CENTER

    May 1, 2009, 00:00

  • PIN11 MODELING THE INPATIENT AND OUTPATIENT COSTS OF METHICILLIN-RESISTANT STAPHYLOCCOCUS AUREUS (MRSA) COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI)- A COMPARISON OF LINEZOLID, VANCOMYCIN, DAPTOMYCIN, AND TIGECYCLINE

    May 1, 2009, 00:00

  • PMH88 A SYSTEMATIC EVALUATION OF PUBLISHED LITERATURE TO ASSESS BURDEN OF TREATMENT-RESISTANT DEPRESSION

    May 1, 2009, 00:00

  • PCN32 ECONOMIC EVALUATION OF SUNITINIB, SORAFENIB, BEVACIZUMAB/ INTERFERON ALPHA AND TEMSIROLIMUS IN FIRST LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN ISRAEL

    May 1, 2009, 00:00

  • PRS37 WHICH SMOKERS GET ADVICE TO QUIT? VARIABLES ASSOCIATED WITH PHYSICIAN ADVICE FOR SMOKING CESSATION

    May 1, 2009, 00:00

  • PCN19 BUDGET IMPACT ANALYSIS OF SARGRAMOSTIM USE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA

    May 1, 2009, 00:00

  • PMS23 AN ECONOMIC ANALYSIS COMPARING THREE COMBINATIONS OF TUMOR NECROSIS FACTOR-ALPHA AGENTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

    May 1, 2009, 00:00

  • PDB22 ECONOMIC EVALUATION OF LONG-ACTING INSULIN ANALOGUES FOR THE TREATMENT OF PATIENTS WITH TYPE-1 AND TYPE-2 DIABETES MELLITUS IN CANADA

    May 1, 2009, 00:00

  • PSY9 USING UTILIZATION RECORDS TO ESTIMATE THE BURDEN OF OBESITY IN ADULTS LIVING IN ONTARIO

    May 1, 2009, 00:00

  • PMH75 AUTISM-RELATED HOSPITALIZATIONS- ESTIMATES FROM 2006 HEALTH CARE COST AND UTILIZATION PROJECT KIDS INPATIENT DATABASE

    May 1, 2009, 00:00

  • PMS22 COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS. RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO

    May 1, 2009, 00:00

  • PND20 COMPLIANCE AND PERSISTENCE OF ORAL CHOLINESTERASE INHIBITORS IN PATIENTS WITH ALZHEIMERS DISEASE

    May 1, 2009, 00:00

  • PMH29 DIRECT COSTS IN OLDER PATIENTS WITH DEPRESSION TREATED AND UNTREATED WITH ANTIDEPRESSANT THERAPY

    May 1, 2009, 00:00

  • PMS30 THE ECONOMIC CONSEQUENCES OF RHEUMATOID ARTHRITIS- ANALYSIS OF THE MEDICAL EXPENDITURE PANEL SURVEY (MEPS) 2005 AND 2006 DATA

    May 1, 2009, 00:00

  • PDB28 EXCESS COSTS OF DIABETES MELLITUS AMONG MEDICARE RECIPIENTS IN A SKILLED NURSING FACILITY SETTING

    May 1, 2009, 00:00

  • PCN34 ECONOMIC EVALUATION OF TEMOZOLOMIDE FOR THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME IN MEXICO

    May 1, 2009, 00:00

  • PGI6 COST EFFECTIVENESS ANALYSIS OF ANTI-TNF-ALPHA; DRUGS FOR REFRACTORY ULCERATIVE COLITIS

    May 1, 2009, 00:00

  • PSY33 PROCESS MEASUREMENT AND CALCULATION IN IV-PCA AT UNIVERSITY HOSPITAL OULU FINLAND

    May 1, 2009, 00:00

  • PND8 THE IMPACT OF GENERIC SUBSTITUTION OF TOPIRAMATE ON HEALTH CARE COSTS- CONVERSION OF THE CANADIAN EXPERIENCE INTO THE SETTINGS OF G4 EUROPEAN COUNTRIES

    May 1, 2009, 00:00

  • PCN80 HEALTH RELATED QUALITY OF LIFE IN THE DIFFERENT STAGES OF BREAST CANCER IN PATIENTS ATTENDED IN THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2009, 00:00

  • PSY30 ECONOMIC BURDEN OF FIBROMYALGIA COMPARED TO OTHER CHRONIC CONDITIONS

    May 1, 2009, 00:00

  • PMH47 REASONS FOR DISCONTINUATION AND CONTINUATION OF ANTIPSYCHOTIC THERAPY FROM PATIENT AND CLINICIAN PERSPECTIVES

    May 1, 2009, 00:00

  • PCV5 DEVELOPMENT OF TESTS FOR EARLY DIAGNOSIS OF PREECLAMPSIA

    May 1, 2009, 00:00

  • PSY41 PATIENT-REPORTED OUTCOME (PRO) LABELING CLAIMS IN PAIN TREATMENT- OVERVIEW OF US AND EUROPEAN DRUG APPROVALS

    May 1, 2009, 00:00

  • PHP75 PHYSICIAN KNOWLEDGE AND CONFIDENCE IN APPROPRIATE MEDICATION PRESCRIBING IN THE ELDERLY- A SURVEY STUDY IN PARMA, ITALY

    May 1, 2009, 00:00

  • PMH16 COST-BENEFIT ANALYSIS OF FOUR ANTIPSYCHOTIC DRUGS FOR THE TREATMENT OF SCHIZOPHRENIA IN COLOMBIA

    May 1, 2009, 00:00

  • PHP90 THE IMPACT OF AN ELECTRONIC PRESCRIBING SOLUTION ON THE SELECTION AND PRESCRIBING OF COST-EFFECTIVE THERAPEUTIC OPTIONS

    May 1, 2009, 00:00

  • PMS6 DEVELOPMENT OF TESTS FOR DIAGNOSIS OF RHEUMATOID ARTHRITIS

    May 1, 2009, 00:00

  • PCV97 TEN-YEARS FOLLOW-UP OF ANTI-HYPERTENSIVE MEDICATIONS WITHIN THE SLOVAK REPUBLIC

    May 1, 2009, 00:00

  • PHP79 ASSESSING THE QUALITY OF CARE IN ITALYS PRIMARY CARE PRACTICES USING ADMINISTRATIVE DATA. IS IT FEASIBLE?

    May 1, 2009, 00:00

  • PHP11 THE IMPACT OF NON-REFERRAL OUTPATIENT CO-PAYMENT ON MEDICAL CARE UTILISATION AND EXPENDITURE IN TAIWAN

    May 1, 2009, 00:00

  • PMH7 PATIENT ASSESSED QUALITY OF LIFE VS. CLINICIAN ASSESSMENT IN A TRIAL OF ARIPIPRAZOLE IN PEDIATRIC PATIENTS WITH BIPOLAR DISORDER

    May 1, 2009, 00:00

  • RR3 USE OF HEALTH CARE SERVICES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATED WITH BUDESONIDE/FORMOTEROL VIA DRY POWDER INHALER (BUD/FM DPI) VERSUS TIOTROPIUM DPI

    May 1, 2009, 00:00

  • PND25 THE IMPACT OF LENNOX-GASTAUT SYNDROME (LGS) ON HEALTH RELATED QUALITY OF LIFE - A CONCEPTUAL MODEL

    May 1, 2009, 00:00

  • PDB14 FORECASTING THE NUMBER OF DIABETIC PATIENTS IN THE UNITED STATES THROUGH 2025

    May 1, 2009, 00:00

  • PRS39 ADHERENCE AMONG COPD SUBJECTS ON TIOTROPIUM AND FLUTICASONE/SALMETEROL

    May 1, 2009, 00:00

  • PMH31 ASSOCIATION BETWEEN CHOICE OF ANTIPSYCHOTIC TREATMENT AND SUBSEQUENT COSTS OF MEDICAL CARE IN PATIENTS WITH BIPOLAR DISORDER

    May 1, 2009, 00:00

  • PCV28 THE CLINICAL IMPACT OF DIFFERENCES BETWEEN TWO MEASURES OF THE INTERNATIONAL NORMALIZED RATIO (INR)

    May 1, 2009, 00:00

  • PRS40 MEDICATION USE AND ASTHMA CONTROL-ANALYZING ECONOMIC TRADEOFFS USING INSURANCE CLAIMS DATA

    May 1, 2009, 00:00

  • PDB13 PATTERNS AND POTENTIAL RISKS OF CO-PRESCRIBING ANTIHYPERGLYCEMICS AND SILYMARIN- A TAIWANESE POPULATION-BASED STUDY

    May 1, 2009, 00:00

  • PHP74 RED BLOOD CELL TRANSFUSION PRACTICES IN VA INTENSIVE CARE UNITS- HOW DO THEY VARY FOR PATIENTS WITH HEART AND CHRONIC KIDNEY DISEASE?

    May 1, 2009, 00:00

  • PMC16 EVALUATING AN ONLINE FREEWARE CALCULATOR AND PLOTTER FOR POWER ANALYSIS AND SAMPLE SIZE ESTIMATION FOR COST EFFECTIVENESS STUDIES

    May 1, 2009, 00:00

  • PND28 THE USE OF ELECTRONIC PATIENT-REPORTED OUTCOMES WITHIN CENTRAL NERVOUS SYSTEM PROTOCOLS

    May 1, 2009, 00:00

  • PHP6 PHYSICIAN KNOWLEDGE OF THE FDA-APPROVED INDICATIONS OF COMMONLY PRESCRIBED DRUGS- RESULTS OF A NATIONAL SURVEY

    May 1, 2009, 00:00

  • PDB37 HYBRID APPLICATIONS OF EXACT COVARIATE MATCHING AND PROPENSITY SCORE IN THE EVALUATION OF PATIENT PERSISTENCE

    May 1, 2009, 00:00

  • PMS55 RHEUMATOLOGIST INVOLVEMENT IN CARE OF PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2009, 00:00

  • PSS11 ECONOMIC BURDEN OF SEVERE CHRONIC HAND ECZEMA/ DERMATITIS IN CANADIAN ADULTS

    May 1, 2009, 00:00

  • PND5 CLINICAL CONSEQUENCES OF GENERIC SWITCHES OF ANTIEPILEPTIC DRUGS-TRANSFER OF CANADIAN CLAIMS DATABASE RESULTS TO GERMANY

    May 1, 2009, 00:00

  • PCV40 COST-EFFECTIVENESS ANALYSIS OF THE INSERTABLE CARDIAC MONITOR FOR DETECTING RECURRENT ATRIAL FIBRILLATION (AF) FOLLOWING RADIOFREQUENCY CATHETER ABLATION (RCA)- A CANADIAN PERSPECTIVE

    May 1, 2009, 00:00

  • PMC63 THE TRANSLATION AND LINGUISTIC VALIDATION OF THE NEUROPATHY TOTAL SYMPTOM SCORE-6 SELF-ASSESSED VERSION (NTSS-6 SA)

    May 1, 2009, 00:00

  • PCV50 COST CONSEQUENCES ANALYSIS OF ANTITHROMBOTIC THERAPIES FOR VENOUS THROMBOEMBOLIC DISEASE (VTE) IN MEDICAL PATIENTS IN MEXICO

    May 1, 2009, 00:00

  • PND13 A COST-CONSEQUENCES ANALYSIS OF THE IMPACT OF A-RATED ANTI-EPILEPTIC DRUG SWITCHING- THE MANAGED CARE PLAN PERSPECTIVE

    May 1, 2009, 00:00

  • PSY7 DISEASE FLARES AMONG PATIENTS WITH CROHNS DISEASE

    May 1, 2009, 00:00

  • PDB16 REPLICATION AND VALIDATION OF THE QUANTIFICATION OF THE RELATIONSHIP BETWEEN PHARMACOLOGIC INTERVENTION, REDUCTIONS IN HBA1C AND REDUCTIONS IN COMPLICATIONS- ITS APPLICATION IN QUANTIFYING THE BENEFITS OF ADDING COLESEVELAM HYDROCHLOR ...

    May 1, 2009, 00:00

  • PCN59 INCIDENCE RATE AND BURDEN OF ILLNESS OF CERVICAL CANCER IN THE UNITED STATES

    May 1, 2009, 00:00

  • PHP33 UNMET PRESCRIPTION MEDICATION NEED DUE TO COST, HEALTH PLAN PROBLEM, AND LACK OF INSURANCE OF CHILDREN IN THE UNITED STATES- RESULTS FROM NATIONAL SURVEY OF CHILDRENS HEALTH 2003 DATA

    May 1, 2009, 00:00

  • PDB54 DULOXETINE THERAPY AND CHANGES IN OPIOID USE AMONG DIABETIC PERIPHERAL NEUROPATHIC PAIN PATIENTS

    May 1, 2009, 00:00

  • PMC9 SIGNIFICANCE OF INCORPORATING COMMUNITY-BASED DATA OF A TARGET POPULATION INTO PHARMACOECONOMIC MODELS

    May 1, 2009, 00:00

  • PCV69 A CONCEPTUAL ANALYSIS OF THE COSTS OF CARE FOR A 'MAJOR BLEED' IN STUDIES OF ANTIPLATELET AND ANTITHROMBOTIC THERAPIES

    May 1, 2009, 00:00

  • PRS36 HOSPITAL RESOURCE UTILIZATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE- AN ANALYSIS OF THE 2005 NATIONAL INPATIENT SAMPLE DATA

    May 1, 2009, 00:00

  • PMC87 COMPARING CHART REVIEW AND MODIFIED DELPHI PANEL RESOURCE DATA COLLECTION METHODS- THE COST OF TREATMENT FOR MULTIPLE MYELOMA IN SWEDEN

    May 1, 2009, 00:00

  • PSY11 ESTIMATION OF CAUSAL EFFECTS OF PHYSICAL ACTIVITY ON OBESITY BY A RECURSIVE BIVARIATE PROBIT MODEL

    May 1, 2009, 00:00

  • PHP52 BUDGETARY POLICIES AND AVAILABLE ACTIONS- A GENERALISATION OF DECISION RULES FOR ALLOCATION AND RESEARCH DECISIONS

    May 1, 2009, 00:00

  • PIN28 SAVING COSTS FROM INFLUENZA IMMUNIZATION AMONG YOUNG CHILDREN-LIVE ATTENUATED VS. INACTIVATED INFLUENZA VACCINATION

    May 1, 2009, 00:00

  • CN2 WHEN IS CANCER CARE COST-EFFECTIVE? A SYSTEMATIC OVERVIEW OF COST-UTILITY ANALYSES IN ONCOLOGY

    May 1, 2009, 00:00

  • PMC85 THE TRANSLATION AND LINGUISTIC VALIDATION OF THE PAR-ENT-QOL QUESTIONNAIRE

    May 1, 2009, 00:00

  • PMS21 ECONOMIC EVALUATION OF THE USE OF HYLAN G-F 20 IN THE HANDLING OF SEVERE KNEE OSTEOARTHROSIS

    May 1, 2009, 00:00

  • PIH36 DEVELOPMENT OF A SPECIFIC QUESTIONNAIRE ASSESSING THE IMPACT ON PARENTS OF AN INFANTS BRONCHIOLITIS HOSPITALIZATION

    May 1, 2009, 00:00

  • PCV17 ASSOCIATION BETWEEN PHARMACY TREATMENT AND OUTCOMES IN PATIENTS WITH CHRONIC HEART FAILURE

    May 1, 2009, 00:00

  • PHP76 25 YEARS OF ECONOMIC EVALUATION IN MEXICO- A SYSTEMATIC REVIEW OF ARTICLES PUBLISHED IN THE ECONOMIC AND MEDICAL LITERATURE- 1984-2009

    May 1, 2009, 00:00

  • PMH11 RISK ASSESSMENT OF POISONING WITH DRUGS OF THERAPEUTIC IMPORTANCE BY TOXICOVIGILANCE

    May 1, 2009, 00:00

  • PMC15 EVALUATING AN ONLINE FREEWARE CALCULATOR FOR A COST EFFECTIVENESS MODEL TO ASSESS THE IMPACT OF MEDICATION COMPLIANCE

    May 1, 2009, 00:00

  • PMS25 COST-EFFECTIVENESS IN OSTEOARTHRITIS PAIN RELIEF TREATMENT WITH NSAIDS - A DETERMINATION AND ESTIMATION OF KEY DRIVERS

    May 1, 2009, 00:00

  • PCV7 BURDEN OF HYPERTENSION AND ASSOCIATED TREATMENT PATTERNS IN EUROPE- A COMPARISON OF FIVE COUNTRIES

    May 1, 2009, 00:00

  • PDB34 THE EFFECT OF MEDICATION CHOICE BETWEEN DULOXETINE AND PREGABALIN ON MEDICATION COMPLIANCE AMONG PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN

    May 1, 2009, 00:00

  • PCV37 ECONOMIC IMPACT OF EDARAVONE THERAPY FOR PATIENTS WITH LACUNAR INFARCTION IN JAPAN

    May 1, 2009, 00:00

  • PCV92 HOW DOES THE OUT-OF-POCKET PAYMENT MATTER TO HYPERTENSIVE PATIENTS CHOICES OF ACCESSING DIFFERENT MEDICAL FACILITIES IN TAIWAN? THE PRELIMINARY STUDY OF A DISCRETE CHOICE EXPERIMENT

    May 1, 2009, 00:00

  • PHP48 LEGISLATIVE ASPECTS OF HEALTH TECHNOLOGY ASSESSMENT IN SLOVAKIA

    May 1, 2009, 00:00

  • PIH11 ECONOMIC EVALUATION ALONGSIDE THE CAFFEINE FOR APNEA OF PREMATURITY (CAP) TRIAL- SHORT TERM OUTCOMES

    May 1, 2009, 00:00

  • PCN10 LUNG CANCER IN THE CHINESE PASSIVE SMOKING POPULATIONS

    May 1, 2009, 00:00

  • CM3 THE IMPACT OF MEDICARE PART D ON ELDERLY PATIENTS COMPLIANCE WITH STATINS

    May 1, 2009, 00:00

  • CV1 ASSOCIATION OF CARDIOMETABOLIC RISK FACTORS AND PREVALENT CARDIOVASCULAR EVENTS

    May 1, 2009, 00:00

  • PND7 RELATION OF HEADACHE FREQUENCY TO HEALTH CARE UTILIZATION, WORK PRODUCTIVITY, AND TOTAL COSTS- RESULTS FROM THE AMERICAN MIGRAINE PREVALENCE AND PREVENTION (AMPP) STUDY

    May 1, 2009, 00:00

  • PIH23 A SYSTEMATIC REVIEW OF THE COST OF FALLS IN OLDER ADULTS- AN INTERNATIONAL PERSPECTIVE

    May 1, 2009, 00:00

  • PIH32 THE BRAZILIAN PORTUGUESE VALIDATION OF THE PROLAPSE-QUALITY OF LIFE QUESTIONNAIRE-P-QOL

    May 1, 2009, 00:00

  • PHP24 COST SAVINGS ASSOCIATED WITH FILLING A THREE-MONTH SUPPLY OF PRESCRIPTION MEDICINES

    May 1, 2009, 00:00

  • PSS15 CHANGES IN HEALTH RELATED UTILITY AMONG ADULTS WITH ATOPIC DERMATITIS TREATED WITH TACROLIMUS OINTMENT COMPARED TO A STANDARD CORTICOSTEROID REGIMEN

    May 1, 2009, 00:00

  • FD4 THE EFFECTS OF NICE HTAS ON DRUG PRESCRIBING AND EXPENDITURES IN THE UNITED STATES

    May 1, 2009, 00:00

  • PCV3 MEDIATING ROLE OF CEREBROVASCULAR DISEASE IN THE ASSOCIATION BETWEEN DIABETES MELLITUS AND DEMENTIA

    May 1, 2009, 00:00

  • RR4 OUTCOMES ASSOCIATED WITH TIOTROPIUM USE IN COPD PATIENTS

    May 1, 2009, 00:00

  • PMS42 THE EFFECT OF LIFESTYLE CHOICES ON THE RISK OF IMPAIRMENT IN RHEUMATOID ARTHRITIS PATIENTS- AN ANALYSIS OF AEROBIC EXERCISE AND CIGARETTE SMOKING

    May 1, 2009, 00:00

  • PIH44 WORK PRODUCTIVITY OF WOMEN EXPERIENCING DOMESTIC VIOLENCE

    May 1, 2009, 00:00

  • CASE2 TOWARDS AN INTEGRATED APPROACH TO THE ASSESSMENT OF SURROGATE OUTCOME DATA

    May 1, 2009, 00:00

  • PUK6 ASSESSMENT OF CARDIOVASCULAR (CV) COMORBIDITY IN PATIENTS WITH OVERACTIVE BLADDER (OAB) DISORDER IN A REAL-WORLD SETTING

    May 1, 2009, 00:00

  • PMS34 AN EXPLORATORY EVALUATION OF THE COST-EFFECTIVENESS OF RITUXIMAB AND ABATACEPT IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO A TUMOUR NECROSIS FACTOR INHIBITOR IN CANADA

    May 1, 2009, 00:00

  • UT1 ON THE ISSUE OF UTILITY MULTIPLICATION- A REVISIT

    May 1, 2009, 00:00

  • PGI15 ADULT CANADIANS SUFFERING FROM ACID RELATED DISEASES- PATIENT REPORTED ATTITUDES, PERCEPTIONS, AND IMPACT ON THEIR LIFE

    May 1, 2009, 00:00

  • PMC13 A QALY ALTERNATIVE FOR COST-EFFECTIVENESS ANALYSIS IN HEALTH CARE

    May 1, 2009, 00:00

  • PCN42 BUDGETARY IMPACT OF METASTATIC RENAL CELL CARCINOMA (MRCC) TREATMENT ON THE COLOMBIAN GENERAL HEALTH SOCIAL SECURITY SYSTEM (SGSSS)

    May 1, 2009, 00:00

  • CV3 THE IMPACT OF PROTON PUMP INHIBITORS ON CARDIOVASCULARRELATED EVENT COSTS IN PATIENTS INITIATING CLOPIDOGREL

    May 1, 2009, 00:00

  • PMC32 RELEVANCE OF CONFERENCE ABSTRACTS AND HAND-SEARCHING IN SYSTEMATIC REVIEWS

    May 1, 2009, 00:00

  • PIN29 INFLUENZA- THE DEMOGRAPHICS AND TIME SPENT IN HOSPITALS OF THOSE INFECTED

    May 1, 2009, 00:00

  • PCV94 ASSESSMENT OF THE STATUS OF HYPERTENSION MANAGEMENT IN NEWLY DIAGNOSED AND ESTABLISHED HYPERTENSION PATIENTS IN PRIMARY CARE PRACTICE

    May 1, 2009, 00:00

  • PMC60 DETERMINING THE MINIMALLY IMPORTANT DIFFERENCES OF FOUR PREFERENCE-BASED HEALTH INDICES- A SIMULATION APPROACH

    May 1, 2009, 00:00

  • PND2 CHRONIC MIGRAINE CRITERIA AND THEIR EFFECTS ON GLOBAL PREVALENCE ESTIMATES- A SYSTEMATIC REVIEW

    May 1, 2009, 00:00

  • PMC31 AN APPLICATION OF MULTINOMIAL LOGIT PROPENSITY SCORE MATCHING IN ADULT ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)

    May 1, 2009, 00:00

  • PDB8 COMPARISON OF DOSING PATTERNS OF DULOXETINE AND PREGABALIN AMONG PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN

    May 1, 2009, 00:00

  • CO3 ESTIMATING DRUG COSTS IN ECONOMIC EVALUATIONS IN IRELAND AND THE UK- AN ANALYSIS OF PRACTICE AND RESEARCH RECOMMENDATIONS

    May 1, 2009, 00:00

  • PMC48 'UNNATURAL' HISTORY- MODELING DISEASE PROGRESSION USING OBSERVATIONAL DATA

    May 1, 2009, 00:00

  • PMS48 GOLIMUMAB, A HUMAN ANTI-TNF-ALPHA MONOCLONAL ANTIBODY, SIGNIFICANTLY IMPROVES SELF-REPORTED PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS- RESULTS FROM THREE PHASE 3 STUDIES

    May 1, 2009, 00:00

  • PGI14 RESPONSIVENESS TO CHANGE AND CONSTRUCT VALIDITY OF THE WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT QUESTIONNAIRE FOR GASTROESOPHAGEAL REFLUX DISEASE (WPAI - GERD) IN SWEDISH PATIENTS

    May 1, 2009, 00:00

  • PIN38 PATIENT PREFERENCES AND STATED ADHERENCE FOR HEPATITIS C VIRUS TREATMENTS

    May 1, 2009, 00:00

  • VA2 COST EFFECTIVENESS ANALYSIS OF THE NEW 10-VALENT PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) IN CANADA

    May 1, 2009, 00:00

  • PHP12 HOW NON-REFERRAL OUTPATIENT CO-PAYMENT IN TAIWAN IMPACTS ON PATIENTS OUT-OF-POCKET COSTS AND PRESCRIPTION PATTERNS

    May 1, 2009, 00:00

  • PHP91 MEDICARE PART DS EFFECT ON PRESCRIBING VOLUME- AVERAGE MONTHLY UTILIZATION OF SELECTED HIGH USE DRUGS IN THE PROTECTED CLASSES BY DIFFERENT SPECIALTIES

    May 1, 2009, 00:00

  • VA4 COMPARING COST-EFFECTIVENESS RESULTS- OF A CROSS-SECTIONAL POPULATION MODEL WITH A COHORT MODEL- THE APPLICATION TO PNEUMOCOCCAL CONJUGATE VACCINATION

    May 1, 2009, 00:00

  • PHP92 EVALUATION OF A WIRELESS HANDHELD MEDICATION MANAGEMENT PROGRAM IN THE PREVENTION OF DRUG-DRUG INTERACTIONS

    May 1, 2009, 00:00

  • PMS12 FIBROMYALGIA- RUSSIAN RHEUMATOLOGISTS KNOWLEDGE

    May 1, 2009, 00:00

  • PSS17 THE RELATIONSHIP OF DRIVING, VISION, AND QUALITY OF LIFE OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NV-ARMD)

    May 1, 2009, 00:00

  • PMS40 UTILITY AND QUALITY OF LIFE OF PATIENTS WITH OSTEOARTHRITIS TREATED WITH THE CYCLOOXYGENASE INHIBITING NITRIC OXIDE DONATOR (CINOD) NAPROXCINOD

    May 1, 2009, 00:00

  • PCN79 HEALTH RELATED QUALITY OF LIFE IN THE DIFFERENT STAGES OF NON-HODGKIN LYMPHOMA IN PATIENTS ATTENDED IN THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2009, 00:00

  • PCN35 COST-EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS VACCINE IN COLOMBIA IN 2007

    May 1, 2009, 00:00

  • PRS29 CAN OLDER, CHRONICALLY ILL ADULTS USE ELECTRONIC DIARIES? COMPLIANCE RATES IN A PROSPECTIVE STUDY OF PATIENTS WITH COPD

    May 1, 2009, 00:00

  • PSY45 CURTAILING LAB-TEST ORDERING IN A MANAGED CARE SETTING THROUGH REDESIGN OF A COMPUTERIZED ORDER-FORM

    May 1, 2009, 00:00

  • PSY48 IMPACT OF DIFFERENT WEIGHT CONTROL MEASURES TAKEN BY THE STUDENTS ON THEIR WEIGHT

    May 1, 2009, 00:00

  • VA3 A GLOBAL COST-EFFECTIVENESS EVALUATION OF THE IMPACT OF POTENTIAL INNOVATIONS IN MEASLES VACCINATION

    May 1, 2009, 00:00

  • PMS36 IMPACT OF A SUPPORT PROGRAM ON THE TREATMENT COMPLIANCE IN OSTEOPOROSIS PATIENTS

    May 1, 2009, 00:00

  • PND14 COST OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS PATIENTS IN THE UNITED KINGDOM

    May 1, 2009, 00:00

  • PDB20 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO INSULIN DETEMIR FROM ORAL ANTIDIABETICS OR NPH IN THE CZECH SETTING; DATA FROM THE PREDICTIVE STUDY

    May 1, 2009, 00:00

  • PHP67 HEALTH STATUS AND ATTITUDES TOWARDS HEALTH INSURANCE IN MEPS SAMPLE POPULATION

    May 1, 2009, 00:00

  • PMH63 EFFECTS OF FISCAL INCENTIVES AND SOCIOECONOMIC FACTORS ON ANTIDEPRESSANT ADHERENCE

    May 1, 2009, 00:00

  • PCV36 THE IMPACT OF A STATIN FORMULARY CHANGE ON HEALTH OUTCOMES AND MEDICAL COSTS

    May 1, 2009, 00:00

  • PND41 DETECTION OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY REPORTS ASSOCIATED WITH NATALIZUMAB PRE- AND POST-RISK MINIMIZATION ACTION PLAN FROM ADVERSE EVENT REPORTING SYSTEM DATABASE

    May 1, 2009, 00:00

  • HM2 USING DECISION MODELING TO MAP PHARMACISTS INTERVENTIONS TO OUTCOMES FOR PATIENTS WITH DIABETES

    May 1, 2009, 00:00

  • PMH32 ANTIPSYCHOTIC TREATMENT CHOICE AND ASSOCIATED COSTS OF MEDICAL CARE IN PATIENTS WITH SCHIZOPHRENIA

    May 1, 2009, 00:00

  • PMH19 ECONOMIC ASSESSMENT OF SECOND-LINE TREATMENT- SWITCHING FROM A GENERIC SSRI TO ESCITALOPRAM, AN SNRI, OR ANOTHER GENERIC SSRI BY PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)

    May 1, 2009, 00:00

  • PCN22 PHARMACOECONOMIC APPLICATIONS IN FORMULARY MANAGEMENT- BUDGET IMPACT ANALYSIS OF CLORFARABINE AT A MAJOR CANCER CENTER

    May 1, 2009, 00:00

  • PMH53 THE ASSOCIATION OF COPAY BURDEN AND OUTCOMES AMONG PATIENTS WITH SCHIZOPHRENIA

    May 1, 2009, 00:00

  • PCN91 PROVISION OF QUALITY OF LIFE INFORMATION AND PHYSICIAN TRUST AMONG FAMILIES OF CHILDREN WITH LIFE-LIMITED CONDITIONS

    May 1, 2009, 00:00

  • PCN28 RETROSPECTIVE CLAIMS DATABASE ANALYSIS OF THE DIRECT MEDICAL COSTS ASSOCIATED WITH SORAFENIB AND SUNITINIB IN THE TREATMENT OF PATIENTS WITH RENAL CELL CARCINOMA WHO ARE UNDER 65 YEARS OLD

    May 1, 2009, 00:00

  • PCV41 ADHERENCE TO GUIDELINES FOR SENSITIVITY ANALYSIS- COSTEFFECTIVENESS ANALYSES OF DUAL ORAL ANTIPLATELET THERAPY

    May 1, 2009, 00:00

  • PND31 FACTORS ASSOCIATED WITH HEALTH-RELATED QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS RECEIVING NATALIZUMAB

    May 1, 2009, 00:00

  • MS4 SOCIETAL COST OF RHEUMATOID ARTHRITIS (RA) IN THE UNITED STATES- METHODOLOGY FOR INCORPORATING INTANGIBLE COSTS

    May 1, 2009, 00:00

  • PMC86 THE IMPACT OF DISEASE ADAPTATION ON GENERAL POPULATION VALUES

    May 1, 2009, 00:00

  • PCN74 COST UTILITY OF POSACONAZOLE VERSUS FLUCONAZOLE/ ITRACONAZOLE THERAPY IN THE PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS AMONG HIGH-RISK NEUTROPENIC PATIENTS IN MEXICO

    May 1, 2009, 00:00

  • CASE1 LESSONS LEARNED- FROM COVERAGE WITH EVIDENCE DEVELOPMENT FOR POSITRON EMISSION TOMOGRAPHY SCANS FOR ONCOLOGIC INDICATIONS

    May 1, 2009, 00:00

  • PCV51 A COST-EFFECTIVENESS ASSESSMENT OF DALTEPARIN AS A PROPHYLACTIC AND THERAPEUTIC AGENT FOR THE MANAGEMENT OF THROMBOEMBOLIC VENOUS DISEASE (VTE) IN MEXICAN ADULT PATIENTS AFTER TOTAL HIP REPLACEMENT

    May 1, 2009, 00:00

  • PIN21 VARIATION IN EFFICIENCY FRONTIERS FOR HIV/AIDS PREVENTION AND TREATMENT

    May 1, 2009, 00:00

  • PMH66 ANTIDEPRESSANTS AND ANTIPSYCHOTICS USE IN CHILDREN-HAS THE UTILIZATION CHANGED AFTER SAFETY WARNINGS?

    May 1, 2009, 00:00

  • PCASE4 THE EVALUATION PROCESS OF A REGIONAL DRUG AND THERAPEUTIC COMMITTEE IN ITALY- THE EXAMPLE OF NEW INDICATIONS FOR BEVACIZUMAB

    May 1, 2009, 00:00

  • PHP36 EFFECT OF THE INTRODUCTION OF VISIT FEE ON THE NUMBER OF VISITS TO GENERAL PRACTITIONERS IN HUNGARY

    May 1, 2009, 00:00

  • PMC29 DEVELOPMENT OF A REGULATORY POST-MARKETING STUDIES DATABASE

    May 1, 2009, 00:00

  • PHC1 COMPARATIVE EFFECTIVENESS OF LOW INTENSITY PULSED ULTRASOUND VERSUS SHAM TREATMENT OF TIBIA FRACTURE IN PATIENTS WITH NONUNION- A DOUBLE-BLIND, MULTI-CENTER RANDOMIZED CONTROLLED TRIAL

    May 1, 2009, 00:00

  • PCN21 BUDGET IMPACT ANALYSIS OF NON - SMALL CELL LUNG CARCINOMA (NSCLC) TREATMENT WITH ERLOTINIB IN POLISH SETTING

    May 1, 2009, 00:00

  • PSS1 META-ANALYSIS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS

    May 1, 2009, 00:00

  • PCN46 PHARMACOECONOMIC EVALUATION OF SUNITINIB MALATE FOR FIRST-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN MEXICO

    May 1, 2009, 00:00

  • PCV8 COMPARING CARDIOVASCULAR EVENT RATES OF STATIN PLUS FIBRATE COMBINATION THERAPY WITH STATIN MONOTHERAPY IN SUBJECTS WITH TYPE-2 DIABETES MELLITUS

    May 1, 2009, 00:00

  • PIN32 PHARMACOECONOMIC RELEVANCE OF ANTI-RETRO VIRAL THERAPY (ART) IN LOW AND MIDDLE INCOME COUNTRIES

    May 1, 2009, 00:00

  • PHP80 AN EVALUATION OF PHARMACOECONOMICS EDUCATION IN COLLEGES OF PHARMACY OUTSIDE THE UNITED STATES 2007-2008 UPDATE

    May 1, 2009, 00:00

  • PHP27 OPTIMIZING THE USE OF MEDICATION IN THE INTRAVENOUS COMPOUND CENTER OF THE CMNO

    May 1, 2009, 00:00

  • PHP30 A SYSTEMATIC LITERATURE REVIEW OF ELECTRONIC MONITORING DEVICES FOR MEASURING MEDICATION ADHERENCE

    May 1, 2009, 00:00

  • PND1 PREVALENCE OF INSOMNIA IN EUROPE- A COMPARISON OF FIVE COUNTRIES

    May 1, 2009, 00:00

  • PIN23 APPLYING THE EFFICIENCY FRONTIER IN PHARMACEUTICAL POLICY MAKING. A CASE STUDY IN TREATMENT RESISTANT HIV/AIDS PATIENTS IN THE GERMAN SETTING

    May 1, 2009, 00:00

  • PIN48 RESPIRATORY SYNCYTIAL VIRUS (RSV) PROPHYLAXIS, DENIALS, AND HOSPITALIZATIONS IN A COMMERCIALLY INSURED POPULATION

    May 1, 2009, 00:00

  • CASE3 HEALTH SERVICES PHARMACEUTICAL COVERAGE FOR COMMON DISEASES MAY BE CHALLENGED BY SIGNIFICANT RISE IN ONCOLOGY DRUG EXPENDITURE

    May 1, 2009, 00:00

  • PMH82 PATTERNS OF AUGMENTATION OF EXTENDED-RELEASE STIMULANTS FOR ADHD WITH IMMEDIATE-RELEASE STIMULANTS IN ADULTS

    May 1, 2009, 00:00

  • PND32 PREDICTORS OF PATIENT- AND PHYSICIAN-REPORTED SATISFACTION/ EASE-OF-USE RATINGS WITH RASAGILINE IN PARKINSONS DISEASE

    May 1, 2009, 00:00

  • PMH86 CONTINUITY OF CARE FOLLOWING HOSPITALIZATION FOR BIPOLAR DISORDER IN PRIVATE PAYER CLAIMS

    May 1, 2009, 00:00

  • PIH26 THE ECONOMIC IMPACT OF SINGLETON, TWIN AND MULTIPLE GESTATION PREGNANCIES IN ALBERTA

    May 1, 2009, 00:00

  • PCV55 COST-EFFECTIVENESS OF VALSARTAN IN JAPAN- RESULTS FROM THE JIKEI HEART STUDY

    May 1, 2009, 00:00

  • MS1 ASSESSMENT OF PREFERENCE AND SATISFACTION WITH A WEEKLY ORAL TABLET VERSUS A 6-MONTH SUBCUTANEOUS INJECTION FOR THE TREATMENT OF OSTEOPOROSIS

    May 1, 2009, 00:00

  • PHP22 POLYPHARMACY IS A MAJOR ISSUE IN THE ELDERLY POPULATION- EVIDENCE FROM A POPULATION-BASED STUDY IN PARMA, ITALY

    May 1, 2009, 00:00
  • «
  • 141
  • 142
  • 143
  • 144
  • 145 (current)
  • 146
  • 147
  • 148
  • 149
  • 150
  • »